Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-160
Closed -$73 985
2025
Q2
$73 Hold
160
﹤0.01% 936
2025
Q1
$66 Hold
160
﹤0.01% 945
2024
Q4
$106 Hold
160
﹤0.01% 966
2024
Q3
$136 Hold
160
﹤0.01% 957
2024
Q2
$107 Hold
160
﹤0.01% 956
2024
Q1
$208 Hold
160
﹤0.01% 822
2023
Q4
$92 Hold
160
﹤0.01% 833
2023
Q3
$107 Hold
160
﹤0.01% 927
2023
Q2
$112 Hold
160
﹤0.01% 910
2023
Q1
$122 Hold
160
﹤0.01% 907
2022
Q4
$154 Hold
160
﹤0.01% 911
2022
Q3
$0 Hold
160
﹤0.01% 982
2022
Q2
$1K Hold
160
﹤0.01% 899
2022
Q1
$1K Buy
+160
New +$810 ﹤0.01% 928

Other funds holding VXRT

GHP Investment Advisors's VXRT Position: Q3 2025 in Review

GHP Investment Advisors sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 160 shares — an estimated $73 sold.

GHP Investment Advisors first reported a position in VXRT in Q1 2022 and held it in 14 quarters. The position peaked at $1K in Q2 2022. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • GHP Investment Advisors reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • GHP Investment Advisors sold 160 Vaxart shares in Q3 2025, an estimated $73.
  • GHP Investment Advisors first reported a position in Vaxart in Q1 2022 and held it in 14 quarters.
  • GHP Investment Advisors's Vaxart position peaked at $1K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on GHP Investment Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.